Anjuli TheresaWiencke-Aschenbrenner

Associate

Munich + 49.89.20.60.42.244

Anjuli Theresa Wiencke-Aschenbrenner joined our New Lawyers Group (NLG) in 2021. The NLG provides our newest lawyers with the opportunity to gain exposure to different practice areas and lawyering styles before making a commitment to a specific practice. Individuals in the NLG may focus on a particular area of practice, or compare practices, during their first year with Jones Day. Anjuli Theresa will be focusing on domestic and cross-border M&A projects as well as private equity and venture capital transactions.

Prior to joining Jones Day, Anjuli Theresa practiced at an international firm where she advised financial sponsors and corporate clients in private equity transactions. She also gained experience in M&A and venture capital deals while working at international law firms in Berlin and in London during her legal studies.

Anjuli Theresa is a member and editor of "breaking.through" a feminist lawyers' association in Germany that aims to make successful female lawyers more visible and to make choosing a legal career more attractive to women and girls.

Experience

  • Web Financial Group sells all its technology business to AllfundsJones Day represented Web Financial Group, S.A. in the sale of all its technology business to Allfunds, one of the world’s leading B2B WealthTech platforms for the fund industry.
  • ProSiebenSat.1 sells moebel.de to XXXLutzJones Day advised ProSiebenSat.1 Media SE in the sale by subsidiary NuCom Group, in which General Atlantic also holds a stake, of moebel.de Einrichten & Wohnen AG to XXXLutz Group.
  • Hilti Group acquires Fieldwire for approximately $300 millionJones Day is advising the Hilti Group in its acquisition of Fieldwire, a San Francisco, California, based construction technology company specialized in construction project management software, for approximately $300 million.
  • ArchiMed acquires Cube Biotech GmbHJones Day advised ArchiMed, a leading Trans-Atlantic private equity healthcare specialist, on its acquisition of Cube Biotech GmbH, a leading provider of expression, purification, and crystallization services and products for membrane proteins.
  • EMERAM Capital Partners sells portfolio company MEONA to Trill ImpactJones Day represented EMERAM Capital Partners GmbH, one of the leading investment companies for medium-sized companies in the German-speaking region, in the sale of its portfolio company MEONA, an innovation leader for clinical software, to the private equity firm, Trill Impact.